Evidence map›Paper›PMID 40555803›Full record

ReviewNature protocols2026

Consensus guidelines for the use of concurrent TMS-fMRI in cognitive and clinical neuroscience.

Alexandra Woolgar, Eva Feredoes, Moataz Assem, Yasmine Bassil, Til O Bergmann, Lysianne Beynel, Michael Burke, Robin F H Cash, Roch M Comeau, Marta M Correia and 23 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Alexandra Woolgar *University of Cambridge, Cambridge, UK. alexandra.woolgar@mrc-cbu.cam.ac.uk.ORCID 0000-0002-8453-7424
Eva Feredoes *University of Reading, Reading, UK.ORCID 0000-0002-1665-1583
Moataz AssemUniversity of Cambridge, Cambridge, UK.
Yasmine BassilEmory University, Atlanta, GA, USA.
Til O BergmannNeuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), Johannes Gutenberg University Medical Center, Mainz, Germany.ORCID 0000-0002-2282-6618
Lysianne BeynelNational Institutes of Health, Bethesda, MD, USA.
Michael BurkeLeibniz Research Center for Working Environment and Human Factors, Dortmund, Germany.ORCID 0000-0002-8516-9889
Robin F H CashUniversity of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0003-2612-9470
Roch M ComeauRogue Research Inc., Montréal, Québec, Canada.
Marta M CorreiaUniversity of Cambridge, Cambridge, UK.
Erhan GencLeibniz Research Center for Working Environment and Human Factors, Dortmund, Germany.ORCID 0000-0001-6514-5479
Gesa HartwigsenCognitive and Biological Psychology, Wilhelm Wundt Institute for Psychology, Leipzig University, Leipzig, Germany.
Jade B JacksonUniversity of Cambridge, Cambridge, UK.ORCID 0000-0002-9066-2627
Matthias KienleMagVenture, Inc., Farum, Denmark.
Patrik KunzLocalite GmbH, Bonn, Germany.
Olga LeticevscaiaUniversity of Reading, Reading, UK.
Bruce LuberNational Institutes of Health, Bethesda, MD, USA.
Maximilian LueckelNeuroimaging Center (NIC), Focus Program Translational Neuroscience (FTN), Johannes Gutenberg University Medical Center, Mainz, Germany.ORCID 0000-0002-5568-5815
Claus MathiesenMagVenture, Inc., Farum, Denmark.
Elizabeth MichaelUniversity of Cambridge, Cambridge, UK.
Ole NumssenMax Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.ORCID 0000-0001-7164-2682
Desmond J OathesUniversity of Pennsylvania, Philadelphia, PA, USA.
Allyson C RosenStanford University School of Medicine, Stanford, CA, USA.
Teresa SchuhmannMaastricht University, Maastricht, The Netherlands.
Anna-Lisa SchulerMax Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.ORCID 0000-0003-0959-280X
Catriona L ScrivenerUniversity of Edinburgh, Edinburgh, UK.ORCID 0000-0002-9507-5587
Axel ThielscherTechnical University of Denmark, Kongens Lyngby, Denmark.ORCID 0000-0002-4752-5854
Martin TikStanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-6571-4413
Yordan TodorovMagVenture, Inc., Farum, Denmark.
Maria VasileiadiMedical University of Vienna, Wien, Austria.
Christian WindischbergerMedical University of Vienna, Wien, Austria.ORCID 0000-0002-9944-0190
Molly S HermillerFlorida State University, Tallahassee, FL, USA.ORCID 0000-0001-7234-4695
Alexander T SackMaastricht University, Maastricht, The Netherlands.ORCID 0000-0002-1471-0885

Funding

Non-invasive Neuromodulation Unit (NNU)ZIAMH002955 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI ZARATE, CARLOS · 2016 to 2025
$40.3M
Individualized Closed Loop TMS for Working Memory EnhancementR01MH120811 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI FAN, YONG, OATHES, DESMOND · 2019 to 2023
$3.5M
Engaging the subgenual cingulate with brain stimulation for depressionR61MH135428 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI OATHES, DESMOND · 2024 to 2025
$2.8M
Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) P33180Deutsche Forschungsgemeinschaft (German Research Foundation) 525127358Deutsche Forschungsgemeinschaft (German Research Foundation) 525176435EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERC-2021-COG 101043747European Commission (EC) 612022Innovationsfonden (Innovation Fund Denmark) 9068-00025BLundbeckfonden (Lundbeck Foundation) R244-2017-196Lundbeckfonden (Lundbeck Foundation) R313-2019-622Max-Planck-Gesellschaft (Max Planck Society) Lise Meitner Excellence FundingNIMH NIH HHS R01 MH120811NIMH NIH HHS R61 MH135428RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/S019170/1RCUK | Medical Research Council (MRC) MC_PC_20046RCUK | Medical Research Council (MRC) SUAG/093/G116768U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) ZIAMH002955
6 · The paper itself

Abstract

Concurrent transcranial magnetic stimulation (TMS) and functional magnetic resonance imaging (TMS-fMRI) provides a step-change in the toolkit of neuroscience research. TMS enables the noninvasive perturbation of ongoing human brain activity, and when coupled to fMRI for the simultaneous read-out of its effects across the brain, concurrent TMS-fMRI enables studies aimed at determining the causal inference of human brain-behavior relationships, with implications for both fundamental research and clinical application. Many of the technical barriers to TMS-fMRI implementation, such as hardware design and setups, have now been overcome, and the research community in the field is rapidly growing. Here, we present the guidelines set by an international consensus, from researchers at all levels and across the fields of cognitive and applied human neuroscience, for the experimental design and practical considerations of concurrent TMS-fMRI via 12 detailed use cases. These guidelines may facilitate the uptake of this approach and simplify the experimental design and planning stages.

Indexed as

Magnetic Resonance ImagingNeurosciencesTranscranial Magnetic StimulationBrainCognitionConsensusGuidelines as TopicHumans

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.